Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

The method effectively identifies banned substances in hair loss and skin disease cosmetics.

Minoxidil in HA-PLGA nanoparticles effectively treats alopecia through skin delivery.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Finasteride in lipid carriers improved hair growth in rats.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Dermocosmetics significantly reduce itch and skin sensitivity in atopic dermatitis patients.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Micro-Imager® helps see how drugs spread in human skin.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

The HG3 hair gel is the most effective for treating seborrheic dermatitis.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The new patch made of cell matrix and a polymer improves wound healing and supports blood vessel growth.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

The new cream is safe and effective for mild to moderate atopic dermatitis.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Technique effectively treats deformities, achieves re-pigmentation, and releases scar contractures.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Tinea corporis significantly reduces quality of life, so early detection and treatment are important.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

New skin imaging, teledermatology, and AI could become key in future dermatology care.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

A new molecule was found to be a safe and effective skin lightener and anti-aging product.

Heat-treated Limosilactobacillus fermentum with menthol, salicylic acid, and panthenol promotes hair growth and balances scalp microbiome in people with androgenetic alopecia.